Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-25-113834
Filing Date
2025-09-09
Accepted
2025-09-09 17:12:12
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 hrtx-20250909.htm S-3 540629
2 EX-4.3 hrtx-ex4_3.htm EX-4.3 498233
3 EX-5.1 hrtx-ex5_1.htm EX-5.1 49942
4 EX-23.1 hrtx-ex23_1.htm EX-23.1 5015
5 EX-FILING FEES hrtx_exfilingfees.htm   iXBRL EX-FILING FEES 114398
6 GRAPHIC img166038578_0.jpg GRAPHIC 56635
7 GRAPHIC img170582792_0.jpg GRAPHIC 28318
  Complete submission text file 0000950170-25-113834.txt   1475644

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT hrtx_exfilingfees_htm.xml XML 14922
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-290143 | Film No.: 251304035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)